ArticleJSES international2025
Clinical outcome of reverse total shoulder arthroplasty (comprehensive system) after failed rotator cuff repair with a medium-term follow-up: comparison with reverse total shoulder arthroplasty for massive rotator cuff tear without osteoarthritis.
Article in JSES international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: We compared the clinical outcomes of primary reverse total shoulder arthroplasty (rTSA) in patients with massive rotator cuff tears (mRCTs) without osteoarthritis (OA), secondary rTSA in patients with failed rotator cuff repair (RCR), and primary rTSA in patients with cuff tear arthropathy (CTA) as a control group. Methods: Among 364 patients who underwent rTSA between March 2014 and August 2019, 153 were included. All patients underwent surgery with a single implant type and were followed for a minimum of 4 years. Patients were categorized into three groups: primary rTSA for mRCT without OA (mRCT group, n = 24), primary rTSA for CTA (CTA group, n = 104), and rTSA for failed rotator cuff repair group (fRCR; fRCR group, n = 25). The mean age was 71.5 ± 6.3 (range, 53-83) years, with a mean follow-up of 54.7 ± 12.9 (range, 48-98) months. Functional outcomes were assessed using the active range of motion, the visual analog scale for pain, the simple shoulder test, the American Shoulder and Elbow Surgeons score, the Quick Disabilities of the Arm, Shoulder, and Hand (Q-DASH) score, and the Constant score at the final follow-up. Results: All functional outcomes significantly improved postoperatively in each group ( Conclusion: Considering the worse clinical outcomes of secondary rTSA after failed RCR compared to primary rTSA for mRCT without OA and/or CTA, careful selection of appropriate candidates for RCR or primary rTSA as a treatment option for mRCT without OA is essential, according to their healing potential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.